Top Page
Haleon PLC
(LSE:HLN)
Haleon PLC (HLN) vs. iShares MSCI United Kingdom ETF (EWC)
Haleon PLC Business Overview & Revenue Model
Haleon PLC Earnings Call Summary
Haleon PLC Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.23B | 11.30B | 10.86B | 9.54B | 9.89B |
| Gross Profit | 6.82B | 6.75B | 6.58B | 5.95B | 5.91B |
| EBITDA | 2.63B | 2.36B | 2.19B | 2.21B | 1.92B |
| Net Income | 1.44B | 1.05B | 1.06B | 1.39B | 1.15B |
Balance Sheet | |||||
| Total Assets | 34.31B | 34.05B | 34.81B | 34.45B | 34.13B |
| Cash, Cash Equivalents and Short-Term Investments | 2.19B | 1.04B | 684.00M | 414.00M | 334.00M |
| Total Debt | 10.10B | 9.46B | 10.44B | 991.00M | 487.00M |
| Total Liabilities | 18.09B | 17.33B | 18.36B | 7.97B | 7.91B |
| Stockholders Equity | 16.17B | 16.61B | 16.33B | 26.36B | 26.11B |
Cash Flow | |||||
| Free Cash Flow | 1.98B | 1.76B | 1.74B | 1.06B | 1.09B |
| Operating Cash Flow | 2.30B | 2.10B | 2.06B | 1.36B | 1.41B |
| Investing Cash Flow | 528.00M | -134.00M | -8.78B | -33.00M | 1.03B |
| Financing Cash Flow | -1.54B | -1.57B | 6.91B | -1.24B | -2.44B |
Haleon PLC Technical Analysis
Haleon PLC Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £200.07M | 5.50 | 33.70% | 172.41% | -0.17% | 2591.96% | |
75 Outperform | £4.40B | 15.72 | 15.79% | 0.15% | 5.83% | 83.35% | |
67 Neutral | £32.21B | 22.70 | 8.80% | 148.18% | -0.61% | 39.00% | |
53 Neutral | £381.32M | ― | -369.20% | ― | 4.50% | 74.32% | |
52 Neutral | kr5.53B | 10.86 | -63.86% | 2.05% | 27.22% | 26.17% |
Haleon PLC Corporate Events
Haleon PLC announced the notification and public disclosure of transactions by persons discharging managerial responsibilities, in line with the UK Market Abuse Regulation. The transactions involved the acquisition of partnership shares and the award of matching shares under the company’s Share Reward Plan by Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer. This disclosure reflects Haleon’s commitment to transparency and regulatory compliance, potentially impacting stakeholder trust and market perception.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £5.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a restructuring of its financial reporting categories to better align with strategic opportunities and enhance financial visibility. The new structure, effective from the 2025 Half Year Results, divides Digestive Health & Other into Digestive Health and Therapeutic Skin Health and Other, while Smokers Health will now be reported under Respiratory Health. This change aims to improve transparency and align reporting with future growth prospects, potentially impacting stakeholders by providing clearer insights into the company’s financial performance.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the vesting of share awards to its Chief Financial Officer, Dawn Allen, under the company’s Share Value Plan and Performance Share Plan. These awards were part of her remuneration package to compensate for incentives forfeited from her previous employment. The vesting includes dividends and is subject to conditions such as continued employment and performance metrics. The shares are also subject to malus and clawback provisions, ensuring alignment with company performance and governance standards.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced that as of June 30, 2025, it has issued a total of 8,988,533,553 ordinary shares, with 3,880,205 held as treasury shares. This results in 8,984,653,348 shares having voting rights, a key figure for shareholders and stakeholders to determine their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. This update is crucial for maintaining transparency and ensuring stakeholders are informed about their voting rights and obligations.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of over one million ordinary shares as part of its ongoing share buyback program. This transaction reflects the company’s commitment to optimizing its capital structure and enhancing shareholder value, potentially impacting its market positioning and signaling confidence in its financial health.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a share buyback transaction, purchasing 1,016,186 ordinary shares for cancellation under its buyback program. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, which may impact voting rights and shareholding notifications under regulatory rules.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 1,011,111 ordinary shares as part of its share buyback program, which was initiated on March 28, 2025. This transaction reflects Haleon’s strategic financial management, potentially enhancing shareholder value by reducing the number of shares in circulation. The company’s registered share capital now stands at 8,992,573,595 ordinary shares, with 8,988,493,390 shares holding voting rights, which may affect shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of over one million ordinary shares as part of its ongoing share buyback program. This move is expected to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing the value of remaining shares.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC has announced the purchase and cancellation of over one million of its own shares as part of a share buyback program initiated in March 2025. This move is likely to impact the company’s share capital structure, reducing the number of shares with voting rights, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a share buyback transaction, purchasing 991,883 ordinary shares for cancellation as part of its ongoing buyback program. This move reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value, impacting the number of shares with voting rights to 8,990,513,705.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a transaction involving a Person Discharging Managerial Responsibilities, Marie-Anne Aymerich, who acquired ordinary shares through dividend reinvestment. This transaction, conducted on the London Stock Exchange, reflects the company’s adherence to UK Market Abuse Regulation requirements and highlights its ongoing commitment to transparency and regulatory compliance.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 966,880 ordinary shares as part of its share buyback program. This transaction affects the company’s share capital, reducing the number of shares with voting rights to 8,992,482,913, which stakeholders can use to assess their interests under regulatory guidelines.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC has announced the repurchase of 971,129 ordinary shares as part of its ongoing share buyback program, initially announced in March 2025. This transaction reflects the company’s strategic focus on optimizing its capital structure and enhancing shareholder value, with the current registered share capital standing at nearly 9 billion ordinary shares.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a share buyback transaction involving the purchase and cancellation of 974,260 ordinary shares as part of its ongoing buyback program. This action, which adjusts the company’s share capital and voting rights, reflects Haleon’s strategic financial management and could influence shareholder interests and market perceptions.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC, a company listed on the London Stock Exchange and New York Stock Exchange, has disclosed transactions by its Persons Discharging Managerial Responsibilities (PDMRs) in accordance with the UK Market Abuse Regulation. The transactions involved the sale and acquisition of ordinary shares by key executives, including Keith Choy, Alan Stewart, Dawn Allen, and Filippo Lanzi, with transactions taking place on the London Stock Exchange. These transactions highlight the ongoing financial activities and shareholding changes within the company’s leadership, potentially impacting investor perceptions and market dynamics.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 972,579 ordinary shares for cancellation as part of its share buyback program. This transaction, which involved shares priced between 395.20p and 399.20p, reflects the company’s ongoing efforts to manage its capital structure effectively. Following this purchase, Haleon’s registered share capital stands at 8,999,475,387 ordinary shares, with 8,995,395,182 shares holding voting rights. This move is part of Haleon’s strategic initiatives to enhance shareholder value and optimize its financial operations.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a share buyback transaction involving the purchase and cancellation of 817,635 ordinary shares as part of its ongoing buyback program. This move is part of Haleon’s strategy to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, which may impact the company’s market positioning and stakeholder interests.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 827,966 ordinary shares as part of its share buyback program initiated in March 2025. This move adjusts the company’s share capital and voting rights, potentially impacting shareholder interests and aligning with regulatory transparency requirements.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC has announced the purchase and cancellation of 815,673 ordinary shares as part of its share buyback programme initiated in March 2025. This transaction impacts the company’s share capital, reducing the number of shares with voting rights, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 794,956 ordinary shares as part of its ongoing share buyback program. This move is part of a strategic effort to manage its capital structure, potentially enhancing shareholder value and reflecting confidence in the company’s financial health. The transaction adjusts the company’s share capital, affecting the number of shares with voting rights, which stakeholders should note for regulatory compliance.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a notification regarding the shareholding of Ed Petter, Chief Corporate Affairs Officer, who received the first tranche of Haleon Ordinary Shares under the company’s Share Value Plan. This award was part of his remuneration package to compensate for incentives forfeited from his previous employment, and it is subject to malus and clawback provisions. This transaction reflects Haleon’s adherence to UK Market Abuse Regulations and highlights the company’s commitment to transparent executive compensation practices.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 794,623 ordinary shares for cancellation as part of its share buyback program initiated in March 2025. This transaction reflects Haleon’s strategic focus on optimizing its capital structure and potentially enhancing shareholder value by reducing the number of shares with voting rights, which now stands at 9,000,455,357.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced that as of May 31, 2025, it has issued a total of 9,005,330,185 ordinary shares, with 4,080,205 held as treasury shares. This results in 9,001,249,980 shares having voting rights, a figure crucial for shareholders and others with notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. This update is significant for stakeholders as it impacts the calculation of their interests in the company.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 797,519 ordinary shares as part of its share buyback program, initially announced in March 2025. This transaction reflects the company’s strategic financial management, potentially enhancing shareholder value and consolidating its market position by reducing the number of shares with voting rights to 9,001,249,980.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 802,236 ordinary shares as part of its share buyback program, initially announced in March 2025. This transaction, aimed at optimizing the company’s capital structure, reduces the number of shares with voting rights to 9,005,256,948, potentially impacting shareholder interests and market positioning.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 810,332 ordinary shares as part of its share buyback program, initially announced in March 2025. This transaction is part of Haleon’s strategy to manage its share capital and potentially enhance shareholder value, reflecting its commitment to maintaining a strong market position.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 816,897 ordinary shares as part of its share buyback program, which was initiated on March 28, 2025. This transaction is part of a strategic move to optimize the company’s capital structure, potentially enhancing shareholder value and reflecting confidence in its long-term growth prospects.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 820,774 ordinary shares as part of its share buyback program, which was initially announced on March 28, 2025. This transaction is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value. Following this purchase, Haleon’s registered share capital consists of over 9 billion ordinary shares, with a significant portion held as treasury shares, impacting the number of shares with voting rights.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a notification regarding a transaction by a person discharging managerial responsibilities. Bláthnaid Bergin, an Independent Non-Executive Director, purchased 6,145 ordinary shares at £4.0427 each on 16 May 2025, as per the UK Market Abuse Regulation disclosure requirements. This transaction could indicate confidence in the company’s future performance and may impact stakeholder perceptions positively.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC has announced the purchase of 825,666 ordinary shares for cancellation as part of its share buyback program initiated in March 2025. This transaction reflects the company’s strategic move to optimize its capital structure, potentially enhancing shareholder value and maintaining a robust market position. The updated share capital now stands at 9,012,587,392 ordinary shares, with 9,008,507,187 shares possessing voting rights.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 840,928 ordinary shares as part of its share buyback programme. This move is part of a strategic effort to manage its capital structure and potentially enhance shareholder value. Following this transaction, Haleon’s registered share capital consists of over 9 billion ordinary shares, with a significant portion held as treasury shares. This adjustment in share capital may influence shareholder voting rights and interests under regulatory guidelines.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 835,518 of its own ordinary shares as part of its share buyback program, which was initially announced in March 2025. This transaction reduces the number of shares with voting rights to 9,010,173,781, potentially impacting shareholder interests and market dynamics.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £4.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC has announced the purchase and cancellation of 820,380 ordinary shares as part of its ongoing share buyback program. This move is aimed at optimizing its capital structure, potentially enhancing shareholder value by reducing the number of shares with voting rights to 9,011,009,299. The transaction reflects Haleon’s strategic financial management and commitment to maintaining a robust market position.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the acquisition of Partnership Shares and the award of Matching Shares under its Share Reward Plan by two of its senior executives, Adrian Morris and Tamara Rogers. This notification, in compliance with the UK Market Abuse Regulation, highlights the company’s commitment to aligning managerial interests with shareholder value, potentially strengthening its market position and stakeholder confidence.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced a transaction involving Marie-Anne Aymerich, an Independent Non-Executive Director, who purchased 21,300 ordinary shares at £4.051 each on the London Stock Exchange. This transaction highlights the confidence of the company’s leadership in Haleon’s market position and future prospects, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase of 814,534 ordinary shares for cancellation as part of its share buyback program. This move is part of the company’s strategy to manage its share capital and potentially enhance shareholder value, impacting the number of shares with voting rights and aligning with regulatory requirements.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Haleon PLC announced the purchase and cancellation of 830,397 ordinary shares as part of its ongoing share buyback programme. This move is part of the company’s strategy to manage its share capital and potentially enhance shareholder value by reducing the number of shares in circulation, which may impact voting rights and shareholding notifications under regulatory guidelines.
Haleon PLC announced the purchase and cancellation of 830,504 ordinary shares as part of its share buyback program initiated in March 2025. This transaction adjusts the company’s registered share capital and the number of shares with voting rights, impacting shareholder notifications under regulatory guidelines.
Haleon PLC announced the purchase and cancellation of 828,853 ordinary shares as part of its ongoing share buyback program. This transaction reflects the company’s strategic financial management, potentially enhancing shareholder value and adjusting its capital structure. The update on the company’s share capital and voting rights is crucial for stakeholders to assess their interests in accordance with regulatory requirements.
Haleon PLC has announced the publication of listing particulars for its £10 billion Euro Medium Term Note Programme, which is guaranteed by the company. This routine update is significant as it underscores Haleon’s commitment to maintaining transparency and accessibility for its investors, potentially impacting its financial strategy and market perception.
Haleon PLC announced the purchase and cancellation of 832,200 ordinary shares as part of its share buyback program. This move is part of a strategic effort to manage its share capital and potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing the value of remaining shares.
Haleon PLC announced the repurchase of 85,611 of its ordinary shares as part of its share buyback program, initially announced in March 2025. This transaction reflects the company’s strategic effort to manage its capital structure and enhance shareholder value, with implications for voting rights and shareholder notifications under regulatory guidelines.